Columbia University College of Physicians and Surgeons
Endometrial cancerCost-effectivenessDostarlimabTrastuzumabHER2Mismatch repair (MMR)
decision analysis, advanced ovarian cancer, homologous recombination deficient tumors, poly(ADP-ribose) polymerase inhibitors
Comorbidity, Treatment, guidelines, ovarian cancer, interaction